A novel prediction of the model is that PI3K + CDK4/6 inhibition is a very effective combination treatment because of its ability to both induce cancer cell death and cell cycle arrest by suppressing two parallel proliferation regulator complexes (cyclin E and CDK2, and cyclin D and CDK4/6). This evidence concerns the gene CDK2 and cancer.